Search - tctmd.com

Displaying 401 - 420 of 1302

Sort: Relevancy | Date

News Daily News

Ischemic Postconditioning Holds No Clinical Benefit for STEMI Patients

March 13, 2015

News Industry News

Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device

March 13, 2015

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

March 11, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Features

Trials Prompt Interventionalists to Reconsider Complete Revascularization for STEMI

March 09, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

March 05, 2015

News Daily News

Surge in Outpatient PAD Procedures Linked to Change in Medicare Reimbursement

March 04, 2015

News Daily News

Coronary Abnormalities May Explain Angina in Patients Without Obstructive Disease

March 04, 2015

News Daily News

Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes

Yael L. Maxwell

March 04, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

February 25, 2015

News Daily News

Outcomes of Endovascular Therapy for Acute Ischemic Stroke Getting Better Over Time

February 25, 2015

News Daily News

Nitrite Injection May Be Cardioprotective in STEMI Patients With Low TIMI Flow

February 25, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

News Opinion Editor's Corner

Endovascular Therapy for Stroke: What Has Changed?

February 23, 2015

News Daily News

Vorapaxar可对先前患过心梗的糖尿病患者起到有效的二级预防作用

February 22, 2015

News Daily News

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

February 22, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

February 22, 2015

News Daily News

Real-World Study Supports Fondaparinux Over Heparin for NSTEMI

February 22, 2015

News Daily News

Study Questions Need for Early Testing in Chest Pain Patients Without Ischemia

February 17, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.